Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "PAS"

1088 News Found

JP Nadda highlights India’s expanding healthcare ecosystem at PGIMER convocation
Policy | April 30, 2026

JP Nadda highlights India’s expanding healthcare ecosystem at PGIMER convocation

Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice


Wanbury's Patalganga site clears Korea FDA inspection with zero observations
Drug Approval | April 30, 2026

Wanbury's Patalganga site clears Korea FDA inspection with zero observations

Patalganga plant received zero observation from USFDA earlier


Pfizer drug delivers breakthrough in late-stage blood cancer trial
Clinical Trials | April 30, 2026

Pfizer drug delivers breakthrough in late-stage blood cancer trial

Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis


Monitra Health raises fresh funding  to scale upBeat® cardiac monitoring platform globally
Medical Device | April 30, 2026

Monitra Health raises fresh funding to scale upBeat® cardiac monitoring platform globally

The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans


Apollo TeleHealth expands integrated healthcare services to Sri City in Tamil Nadu
Hospitals | April 30, 2026

Apollo TeleHealth expands integrated healthcare services to Sri City in Tamil Nadu

New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities


Apollo launches its 76th hospital, boosts tech-led healthcare in India
Hospitals | April 28, 2026

Apollo launches its 76th hospital, boosts tech-led healthcare in India

Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof


Lilly buys Ajax Therapeutics for up to $2.3 billion to target rare blood cancers
Biopharma | April 28, 2026

Lilly buys Ajax Therapeutics for up to $2.3 billion to target rare blood cancers

Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026


Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report
Biopharma | April 28, 2026

Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report

Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation


Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26
Biopharma | April 27, 2026

Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26

Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%


Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle